Locus Biosciences logo

Locus Biosciences

Locus Biosciences is a biotechnology company developing CRISPR-Cas3-engineered precision antibacterial products.

8

Funding Rounds

$117.5m

Money raised

Overview

Locus Biosciences is a biotechnology company developing CRISPR-Cas3-engineered precision antibacterial products.

Funding

Funding series

Funding Series Analysis

The company Locus Biosciences has raised a total of $59m in funding over 8 rounds.

Key Insights:

  • Locus Biosciences Series B round, May 18, 2022: $35m
  • Locus Biosciences Series A round, November 2017: $19m
  • Lous Biosciences , July 2017: $5m
  • Locus Biosciences Venture round, April 2020: $20m
  • Locus Biosciences Grant (money), November 2020: $12.5m
  • Locus Biosciences Series A Funding Round November 2017: $19m
  • Locus Biosciences Series A Funding Round July 2018: $7m
  • Locus Biosciences Grant (money), August 2020: $3k
Locus Biosciences logo
Locus Biosciences Series B round, May 18, 2022 $35m
Locus Biosciences logo
Locus Biosciences Series A round, November 2017 $19m
Locus Biosciences logo
Lous Biosciences , July 2017 $5m
Locus Biosciences logo
Locus Biosciences Venture round, April 2020 $20m
Locus Biosciences logo
Locus Biosciences Grant (money), November 2020 $12.5m
Locus Biosciences logo
Locus Biosciences Grant (money), August 2020 $3k
Locus Biosciences logo
Locus Biosciences Series A Funding Round November 2017 $19m
Locus Biosciences logo
Locus Biosciences Series A Funding Round July 2018 $7m